Impact of diabetes control on mortality by race in a national cohort of veterans

Annals of Epidemiology

Volumn 23, Issue 2, 2013, Pages 74-79

  Hunt, Kelly J ^a,b   Gebregziabher, Mulugeta ^a,b   Lynch, Cheryl P ^a,b   Echols, Carrae ^a,b   Mauldin, Patrick D ^a,b   Egede, Leonard E ^a,b  

^a RALPH H JOHNSON VA MEDICAL CENTER   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Hemoglobin A1c; Medication adherence; Mortality; Race; Retrospective cohort; Type 2 diabetes

Indexed keywords

HEMOGLOBIN A1C; INSULIN; ORAL ANTIDIABETIC AGENT;

ADULT; AGED; ARTICLE; CAUCASIAN; COHORT ANALYSIS; COMORBIDITY; DIABETES CONTROL; FEMALE; FOLLOW UP; HISPANIC; HUMAN; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MALE; MARRIAGE; MORTALITY; NEGRO; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT COMPLIANCE; PREDICTION; PRIORITY JOURNAL; RURAL AREA; URBAN AREA; VETERAN;

ADULT; AFRICAN AMERICANS; AGED; AGED, 80 AND OVER; BLOOD GLUCOSE; CONTINENTAL POPULATION GROUPS; DIABETES MELLITUS, TYPE 2; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FOLLOW-UP STUDIES; HEMOGLOBIN A, GLYCOSYLATED; HISPANIC AMERICANS; HUMANS; HYPOGLYCEMIC AGENTS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; MORTALITY; PREVALENCE; PROPORTIONAL HAZARDS MODELS; RESIDENCE CHARACTERISTICS; RETROSPECTIVE STUDIES; SOCIOECONOMIC FACTORS; UNITED STATES; VETERANS;

EID: 84872138388     PISSN: 10472797     EISSN: 18732585     Source Type: Journal    
DOI: 10.1016/j.annepidem.2012.11.002     Document Type: Article

References (39)

1. VA/DoD Clinical Practice Guideline for the Management of Diabetes Mellitus in Primary Care. In: VA/DoD, editor.
2. American Diabetes Association Standards of medical care in diabetes-2011. Diabetes Care 2011, 34(Suppl. 1):S11-S61.
3. Duckworth W., Abraira C., Moritz T., Reda D., Emanuele N., Reaven P.D., et al. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med 2009, 360(2):129-139.
4. Gerstein H.C., Miller M.E., Byington R.P., Goff D.C., Bigger J.T., Buse J.B., et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008, 358(24):2545-2559.
5. Mattila T.K., De Boer A. Influence of intensive versus conventional glucose control on microvascular and macrovascular complications in type 1 and 2 diabetes mellitus. Drugs 2010, 70(17):2229-2245.
6. Turnbull F.M., Abraira C., Anderson R.J., Byington R.P., Chalmers J.P., Duckworth W.C., et al. Intensive glucose control and macrovascular outcomes in type 2 diabetes. Diabetologia 2009, 52(11):2288-2298.
7. Stettler C., Allemann S., Jüni P., Cull C.A., Holman R.R., Egger M., et al. Glycemic control and macrovascular disease in types 1 and 2 diabetes mellitus: meta-analysis of randomized trials. Am Heart J 2006, 152(1):27-38.
8. Boussageon R., Bejan-Angoulvant T., Saadatian-Elahi M., Lafont S., Bergeonneau C., Kassaï B., et al. Effect of intensive glucose lowering treatment on all cause mortality, cardiovascular death, and microvascular events in type 2 diabetes: meta-analysis of randomised controlled trials. BMJ 2011, 343:d4169.
9. Selvin E., Marinopoulos S., Berkenblit G., Rami T., Brancati F.L., Powe N.R., et al. Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus. Ann Intern Med 2004, 141(6):421-431.
10. Nathan D.M., Kuenen J., Borg R., Zheng H., Schoenfeld D., Heine R.J. Translating the A1C assay into estimated average glucose values. Diabetes Care 2008, 31(8):1473-1478.
11. Miller D.R., Safford M.M., Pogach L.M. Who has diabetes? Best estimates of diabetes prevalence in the Department of Veterans Affairs based on computerized patient data. Diabetes Care 2004, 27(Suppl. 2):B10-B21.
12. West A.N., Lee R.E., Shambaugh-Miller M.D., Bair B.D., Mueller K.J., Lilly R.S., et al. Defining "rural" for veterans' healthcare planning. J Rural Health 2010, 26(4):301-309.
13. Department of Veterans Affairs Field Research Advisory Committee. Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Field Research Advisory Committee Operating Procedures. 2004. [accessed 04.12.12]. http://www.research.va.gov/about/frac/FRAC-ops.pdf.
14. Quan H., Sundararajan V., Halfon P., Fong A., Burnand B., Luthi J.C., et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care 2005, 43(11):1130-1139.
15. Cox D.R. Regression models and life tables. J R Stat Soc Ser B 1972, (34):187-220.
16. Lin D.Y., Wei L.J., Ying Z. Checking the Cox model with cumulative sums of martingale-based residuals. Biometrika 1993, 80:557-572.
17. Fisher L.D., Lin D.Y. Time-dependent covariates in the Cox proportional-hazards regression model. Annu Rev Public Health 1999, 20:145-157.
18. Khaw K.T., Wareham N., Bingham S., Luben R., Welch A., Day N. Association of hemoglobin A1c with cardiovascular disease and mortality in adults: the European prospective investigation into cancer in Norfolk. Ann Intern Med 2004, 141(6):413-420.
19. Shalev V., Chodick G., Bialik M., Green M.S., Heymann A.D. In a population-based cohort of diabetes patients, men and women had similar risks for all-cause mortality. J Clin Epidemiol 2007, 60(1):86-93.
20. Lynch C.P., Gebregziabher M., Echols C., Gilbert G.E., Zhao Y., Egede L.E. Racial disparities in all-cause mortality among veterans with type 2 diabetes. J Gen Intern Med 2010, 25(10):1051-1056.
21. Stratton I.M., Adler A.I., Neil H.A., Matthews D.R., Manley S.E., Cull C.A., et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 2000, 321(7258):405-412.
22. Kirk J.K., D'Agostino R.B., Bell R.A., Passmore L.V., Bonds D.E., Karter A.J., et al. Disparities in HbA1c levels between African-American and non-Hispanic white adults with diabetes: a meta-analysis. Diabetes Care 2006, 29(9):2130-2136.
23. Selvin E., Steffes M.W., Ballantyne C.M., Hoogeveen R.C., Coresh J., Brancati F.L. Racial differences in glycemic markers: a cross-sectional analysis of community-based data. Ann Intern Med 2011, 154(5):303-309.
24. Herman W.H., Dungan K.M., Wolffenbuttel B.H., Buse J.B., Fahrbach J.L., Jiang H., et al. Racial and ethnic differences in mean plasma glucose, hemoglobin A1c, and 1,5-anhydroglucitol in over 2000 patients with type 2 diabetes. J Clin Endocrinol Metab 2009, 94(5):1689-1694.
25. Herman W.H., Ma Y., Uwaifo G., Haffner S., Kahn S.E., Horton E.S., et al. Differences in A1C by race and ethnicity among patients with impaired glucose tolerance in the Diabetes Prevention Program. Diabetes Care 2007, 30(10):2453-2457.
26. Ziemer D.C., Kolm P., Weintraub W.S., Vaccarino V., Rhee M.K., Twombly J.G., et al. Glucose-independent, black-white differences in hemoglobin A1c levels: a cross-sectional analysis of 2 studies. Ann Intern Med 2010, 152(12):770-777.
27. Egede L.E., Gebregziabher M., Hunt K.J., Axon R.N., Echols C., Gilbert G.E., et al. Regional, geographic, and racial/ethnic variation in glycemic control in a national sample of veterans with diabetes. Diabetes Care 2011, 34(4):938-943.
28. Osterberg L., Blaschke T. Adherence to medication. N Engl J Med 2005, 353(5):487-497.
29. Bartels D. Adherence to oral therapy for type 2 diabetes: opportunities for enhancing glycemic control. J Am Acad Nurse Pract 2004, 16(1):8-16.
30. Schectman J.M., Nadkarni M.M., Voss J.D. The association between diabetes metabolic control and drug adherence in an indigent population. Diabetes Care 2002, 25(6):1015-1021.
31. Shenolikar R.A., Balkrishnan R., Camacho F.T., Whitmire J.T., Anderson R.T. Race and medication adherence in Medicaid enrollees with type-2 diabetes. J Natl Med Assoc 2006, 98(7):1071-1077.
32. Adams A.S., Trinacty C.M., Zhang F., Kleinman K., Grant R.W., Meigs J.B., et al. Medication adherence and racial differences in A1C control. Diabetes Care 2008, 31(5):916-921.
33. Grant R., Adams A.S., Trinacty C.M., Zhang F., Kleinman K., Soumerai S.B., et al. Relationship between patient medication adherence and subsequent clinical inertia in type 2 diabetes glycemic management. Diabetes Care 2007, 30(4):807-812.
34. Trinacty C.M., Adams A.S., Soumerai S.B., Zhang F., Meigs J.B., Piette J.D., et al. Racial differences in long-term adherence to oral antidiabetic drug therapy: a longitudinal cohort study. BMC Health Serv Res 2009, 9:24.
35. Ho P.M., Rumsfeld J.S., Masoudi F.A., McClure D.L., Plomondon M.E., Steiner J.F., et al. Effect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitus. Arch Intern Med 2006, 166(17):1836-1841.
36. Lau D.T., Nau D.P. Oral antihyperglycemic medication nonadherence and subsequent hospitalization among individuals with type 2 diabetes. Diabetes Care 2004, 27(9):2149-2153.
37. Heisler M., Vijan S., Makki F., Piette J.D. Diabetes control with reciprocal peer support versus nurse care management: a randomized trial. Ann Intern Med 2010, 153(8):507-515.
38. Kuo Y.F., Raji M.A., Markides K.S., Ray L.A., Espino D.V., Goodwin J.S. Inconsistent use of diabetes medications, diabetes complications, and mortality in older Mexican Americans over a 7-year period: data from the Hispanic established population for the epidemiologic study of the elderly. Diabetes Care 2003, 26(11):3054-3060.
39. Balkrishnan R., Rajagopalan R., Camacho F.T., Huston S.A., Murray F.T., Anderson R.T. Predictors of medication adherence and associated health care costs in an older population with type 2 diabetes mellitus: a longitudinal cohort study. Clin Ther 2003, 25(11):2958-2971.